Mind your gut microbiota for your metabolism and heart ! - a Metacardis international event 

September 28th and 29th, 2018

 

Friday, September 28th, 2018


9:00    Welcome address and introduction
           Karine Clément: The Metacardis project


9:30    MetaCardis Keynote Speaker
           Prof Dusko Ehrlich, INRA: History of metagenomics


10:30    Coffee Break

10:45    Diabetes and Obesity I
             Principal investigators (25’ presentation, 5’ discussion)
             Fredrik Bäckhed: Translational approaches to delineate the role of microbiome in metabolic diseases
             Max Nieuwdorp: FMT and insulin sensitivity?
             

              Unpublished results from young investigators (15’)
             Karen Assmann: Immune cells and gut metagenomics
             Gwen Falony: Quantitative profiling of the gut microbiota – impacts for clinical research

12:30    LUNCH

13:30    Diabetes and Obesity II
             Principal investigators (25’ presentation, 5’ discussion)
             Hervé Blottière: Commensal bacteria and the intestine
           

             Results from the MetaCardis MetaTransition
             Unpublished results from young investigators (15’):
             Judith Aron: Bariatric surgery and metagenomics
             Francois Brial: Microbial metabolites in rodent models of insulin resistance


15:00    Coffee Break

15:30    Cardiovascular diseases
             Principal investigators (25’ presentation, 5’ discussion)
             Oluf Pedersen: Results from the MetaCardis MetaCoronary synopsis
             Kristiansen K.: The Microbiome and atherosclerosis.
             

              Unpublished results from young investigators (15’)
             Sebastien Fromentin: Title to be announced

 

17:00    Focus on Big Data
             Adrien Basdevant: Title to be announced

18:00    Evening event: Poster session with cocktail

 

Saturday, September 29th, 2018


9:00    Drug-related effects
           Principal investigators (25’ presentation, 5’ discussion)
           Peer Bork: Importance of drugs in metagenomic profiles
           Valentina Tremaroli: Metformin and diabetes


           Unpublished results from young investigators (15’)
           Sofia Forslund: Elucidating drug effects on the microbiota

10:30  Coffee Break

10:45  NAFLD/NASH
           Principal investigators (25’ presentation, 5’ discussion)
           Philippe Gérard: Gut metagenomics and liver disease: lessons from animal models
           Marc Dumas: Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women
           

           Unpublished results from young investigators (15’)
           Presentation from the EPoS H2020 consortium

12:00  The future of the gut microbiota in CMDs
            Eran Elinav: Future of Metagenomics in metabolic diseases

13:00   Conference closing remarks


13:30   Departure



Please note: this is a preliminary program, modifications might be necessary.

 

 Please register here

Go to top
JSN Blank template designed by JoomlaShine.com

Our site uses cookies. We'll assume that you are OK with this if you browse further. To find out more about the cookies we use, see our Cookie Policy.

I accept cookies from this site